Roche's Elecsys pTau181 assay gives clinical labs a key role in the initial evaluation of cognitive decline, helping to rule out amyloid pathology earlier in the diagnostic process.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
The upgrade leverages technology by Ultima Genomics and processing at the Gene by Gene lab.
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
